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Abstract: Chemical examination of a Chinese soft coral Lobophytum pauciflorum resulted 
in the isolation of five new biscembranoids named lobophytones O–S (1–5) and a new 
“monomeric” cembrane lobophytone T (6). The structures of the new compounds were 
elucidated by interpretation of 1D and 2D NMR (COSY, HSQC, HMBC, and NOESY) 
spectroscopic data in association with MS and IR data. Lobophytone Q showed significant 
inhibition against lipopolysaccharide (LPS)-induced nitric oxide (NO) release in mouse 
peritoneal macrophages, while lobophytones Q and T showed inhibitory activities against 
the bacteria S. aureus and S. pneumoniae. 
Keywords: soft coral; Lobophytum pauciflorum; lobophytones O–T; structure elucidation; 
NO inhibition; antibiotic activity 
 
1. Introduction 
Biscembranes are a class of marine natural products with unusual structure patterns, which are 
mainly found in the marine soft coral genus of Sarcophyton (S. tortuosum, S. glaucum, S. latum, and 
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S. elegans).  They  are  supposed  to  be  biogenetically  derived  by  a  Diels–Alder  cycloaddition  of 
cembranoid-diene  and  cembranoid-dienophile  [1–8].  Recently,  we  found  the  soft  coral 
Lobophytum pauciflorum also contains a variety of biscembrane analogues, but they presented the 
structure pattern with antipodal Diels–Alder cycloaddition and were named isobiscembranoids [9]. 
This finding provided a new marine organism to enrich the chemical diversity of biscembranoids. Our 
continuing  interest  in  the  chemical  diversity  of  this  specimen  led  to  the  isolation  of  five  new 
biscembranoids (1–5) and a new monomeric cembrane (6) (Figure 1). This paper reports the structural 
elucidation of these new compounds and their bioactivity. 
Figure 1. Structures of lobophytones O–T (1–6). 
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2. Results and Discussion 
Repeated column chromatography of the EtOAc-soluble fraction obtained from the EtOH extract of 
the  soft  coral  L.  pauciflorum  led  to  the  isolation  of  five  biscembranoids  and  a  cembranoid.  All 
biscembranoids shared the partial structure related to methyl tortuosoate, a cembranoid-dienophile [6]. 
Lobophytone  O  (1)  has  a  molecular  formula  of  C41H64O9  as  determined  by  HR-ESIMS 
m/z 723.4428 [M + Na]
+ (calcd for C41H64NO9Na, 723.4442) and NMR data, requiring 10 degrees of 
unsaturation. The 
1H NMR spectrum exhibited the resonances for nine methyls including two olefinic 
methyl  singlets  (H  1.65,  1.66)  and  an  OMe  (H  3.42),  while  the 
13C  NMR  spectrum  presented 
41 carbon resonances including three ketone and one ester carbonyl carbon, four olefinic carbons, and 
five oxygen-bearing sp
3 carbons. Six degrees of unsaturation, as accounted by the functional groups 
out of 10 in the molecule, suggested the presence of a tetracyclic nucleus. The 
1H and 
13C NMR data of 1 
featured a biscembrane  skeleton,  closely  related to  that of ximaolide C as  formerly isolated from 
Sarcophyton tortuosum [3]. COSY in association with HMQC relationships enabled all protons and 
their corresponding carbons in the molecule to be assigned (Tables 1 and 2). Comparison of NMR data 
revealed that rings A and B of 1 were the same as in ximaolide C. The difference was found in ring C, 
where a hydroxy group of 1 replaced a chlorine atom at C-31 of ximaolide C. This was evident from 
the presence of a hydroxy proton at H 3.98 (s), and its HMBC correlations with C-30 (C 89.2) and  
C-31 (C 73.6), and by the missing chlorine isotope pattern in the mass spectrum. Mar. Drugs 2010, 8  
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Table 1. 
13C NMR data of lobophytones O–S (1–5) ( 39.5, DMSO-d6). 
Position  1  2  3  4  5 
1  49.4 (Cq)  49.4 (Cq)  49.3 (Cq)  48.5 (Cq)  49.9 (Cq) 
2  43.9 (CH)  43.8 (CH)  43.9 (CH)  45.9 (CH)  44.0 (CH) 
3  213.8 (Cq)  213.8 (Cq)  213.8 (Cq)  212.1 (Cq)  213.9 (Cq) 
4  54.1 (CH2)  54.0 (CH2)  54.1 (CH2)  50.4 (CH2)  53.9 (CH2) 
5  27.3 (CH)  27.3 (CH)  27.3 (CH)  26.9 (CH)  27.3 (CH) 
6  38.0 (CH2)  37.9 (CH2)  38.0 (CH2)  37.0 (CH2)  38.0 (CH2) 
7  26.0 (CH2)  26.0 (CH2)  26.0 (CH2)  24.4 (CH2)  26.0 (CH2) 
8  34.1 (CH2)  34.0 (CH2)  34.1 (CH2)  32.7 (CH2)  34.1 (CH2) 
9  47.6 (CH)  47.5 (CH)  47.7 (CH)  46.4 (CH)  47.8 (CH) 
10  213.3 (Cq)  213.3 (Cq)  213.3 (Cq)  213.6 (Cq)  213.1 (Cq) 
11  30.9 (CH2)  31.0 (CH2)  30.9 (CH2)  34.9 (CH2)  30.9 (CH2) 
12  51.8 (CH)  51.8 (CH)  51.7 (CH)  51.7 (CH)  51.3 (CH) 
13  210.0 (Cq)  209.9 (Cq)  209.9 (Cq)  211.5 (Cq)  210.3 (Cq) 
14  45.9 (CH2)  45.8 (CH2)  45.9 (CH2)  46.9 (CH2)  46.2 (CH2) 
15  28.7 (CH)  28.7 (CH)  28.7 (CH)  28.8 (CH)  28.9 (CH) 
16  21.5 (CH3)  21.5 (CH3)  21.5 (CH3)  21.2 (CH3)  21.5 (CH3) 
17  17.6 (CH3)  17.6 (CH3)  17.6 (CH3)  18.3 (CH3)  17.7 (CH3) 
18  17.6 (CH3)  17.6 (CH3)  17.6 (CH3)  17.1 (CH3)  17.7 (CH3) 
19  22.9 (CH3)  22.9 (CH3)  22.9 (CH3)  22.1 (CH3)  22.8 (CH3) 
20  174.8 (Cq)  174.7 (Cq)  174.7 (Cq)  173.8 (Cq)  174.6 (Cq) 
21  43.7 (CH)  43.5 (CH)  43.7 (CH)  50.2 (CH)  43.2 (CH) 
22  128.6 (CH)  129.4 (CH)  130.0 (CH)  124.6 (CH)  124.6 (CH) 
23  137.8 (Cq)  136.9 (Cq)  136.2 (Cq)  135.9 (Cq)  133.7 (Cq) 
24  33.5 (CH2)  32.9 (CH2)  34.0 (CH2)  36.7 (CH2)  37.3 (CH2) 
25  33.1 (CH2)  31.1 (CH2)  34.8 (CH2)  24.4 (CH2)  23.8 (CH2) 
26  70.4 (CH)  73.5 (CH)  65.1 (CH)  77.8 (CH)  125.1 (CH) 
27  85.1 (Cq)  83.2 (Cq)  84.8 (Cq)  74.7 (Cq)  132.8 (Cq) 
28  35.9 (CH2)  36.1 (CH2)  36.8 (CH2)  39.7 (CH2)  35.6 (CH2) 
29  28.1 (CH2)  28.0 (CH2)  28.0 (CH2)  27.6 (CH2)  25.1 (CH2) 
30  89.2 (CH)  89.6 (CH)  90.1 (CH)  80.0 (CH)  59.8 (CH) 
31  73.6 (Cq)  73.3 (Cq)  73.2 (Cq)  80.5 (Cq)  59.7 (Cq) 
32  40.8 (CH2)  41.5 (CH2)  40.7 (CH2)  41.5 (CH2)  39.6 (CH2) 
33  64.0 (CH)  64.1 (CH)  63.9 (CH)  24.4 (CH2)  62.6 (CH) 
34  135.6 (Cq)  135.2 (Cq)  135.2 (Cq)  132.8 (Cq)  133.1 (Cq) 
35  123.2 (Cq)  123.2 (Cq)  123.6 (Cq)  123.3 (Cq)  127.6 (Cq) 
36  32.5 (CH2)  32.6 (CH2)  32.5 (CH2)  32.1 (CH2)  32.6 (CH2) 
37  18.4 (CH3)  18.4 (CH3)  18.3 (CH3)  20.1 (CH3)  18.7 (CH3) 
38  20.6 (CH3)  20.3 (CH3)  20.2 (CH3)  17.9 (CH3)  17.6 (CH3) 
39  20.3 (CH3)  20.8 (CH3)  20.3 (CH3)  25.4 (CH3)  17.3 (CH3) 
40  23.5 (CH3)  23.4 (CH3)  23.5 (CH3)  15.5 (CH3)  20.3 (CH3) 
OMe  51.2 (CH3)  51.1 (CH3)  51.2 (CH3)  51.0 (CH3)  51.2 (CH3) 
Ac    171.3 (Cq)       
    21.4 (CH3)       
 Mar. Drugs 2010, 8  
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Table 2. 
1H NMR data of lobophytones O–S (1–5) ( 2.50, DMSO-d6). 
Position  1  2  3  4  5 
2  3.47 t (8.3)  3.45 m  3.47 t (8.8)  3.49 m  3.59 t (8.1) 
4  3.09 dd (10.3, 19.6) 
2.40 d (19.6) 
3.09 dd (10.3, 19.5) 
2.40 d (19.5) 
3.09 dd (10.3, 20.0) 
2.40 d (20.0) 
2.61 dd (6.9, 17.8) 
2.32 m 
3.06 dd (10.3, 19.6) 
2.44 d (19.6) 
5  1.68 m  1.69 m  1.67 m  1.85 m  1.63 m 
6  1.01 m 
1.07 m 
1.01 m 
1.06 m 
0.97 m  1.03 m 
0.87 m 
0.96 m 
1.00 m 
7  1.10 m 
1.01 m 
1.12 m 
1.00 m 
1.08 m 
1.00 m 
0.95 m  0.94 m 
1.07 m 
8  1.43 m 
1.36 m 
1.49 m 
1.35 m 
1.43 m 
1.35 m 
1.40 m  1.38 m 
1.40 m 
9  2.33 m  2.33 m  2.32 m  2.38 m  2.30 m 
11  2.80 dd (10.3, 16.6) 
1.84 d (16.6) 
2.80 m 
1.84 m 
2.80 dd (10.5, 16.9) 
1.83 d (16.9) 
2.73 dd (2.7, 16.9) 
2.15 dd (2.4, 16.9) 
1.88 d (20.0) 
2.82 dd (10.5, 20.0) 
12  2.88 m  2.87 m  2.89 m  2.89 m  2.89 brd (10.5) 
14  2.86 d (19.3) 
2.72 d (19.3) 
2.88 d (19.3) 
2.74 d (19.3) 
2.86 d (19.6) 
2.72 d (19.6) 
2.96 m  
2.90 m 
2.94 d (19.6) 
2.69 d (19.6) 
15  2.33 m  2.34 m  2.32 m  2.07 m  2.22 m 
16  0.95 d (6.7)  0.96 d (6.6)  0.95 d (6.9)  0.91 d (6.9)  0.92 d (6.6) 
17  0.63 d (6.7)  0.63 d (6.6)  0.63 d (6.9)  0.71 d (6.9)  0.61 d (6.6) 
18  1.05 d (6.9)  1.05 d (6.6)  1.05 d (7.0)  1.07 d (7.1)  1.04 d (6.9) 
19  0.81 d (6.9)  0.81 d (6.6)  0.81 d (6.9)  0.81 d (6.9)  0.81 d (6.6) 
21  3.38 d (10.5)  3.47 d (10.3)  3.38 d (10.3)  3.23 m  3.20 d (11.0) 
22  4.78 d (10.5)  4.85 d (10.3)  4.87 d (10.3)  4.94 d (11.5)  4.70 d (11.0) 
24  2.02 m 
1.91 m 
2.13 m 
1.51 m 
2.18 m 
1.96 m 
2.38 m 
1.87 m 
2.07 m 
1.92 m 
25  1.65 m 
1.36 m 
1.80 m 
1.60 m 
2.08 m 
1.66 m 
1.82 m 
1.63 m 
2.22 m 
2.00 m 
26  3.01 brd (10.5)  4.56 d (10.8)  3.55 d (11.7)  3.39 m  4.72 br Mar. Drugs 2010, 8  
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Table 2. Cont. 
28  2.25 m 
1.38 m 
1.71 m 
1.45 m 
2.32 m 
1.62 m 
1.58 m 
1.42 m 
2.10 m 
1.91 m 
29  1.67 m 
1.36 m 
1.71 m 
1.43 m 
1.75 m 
1.40 m 
1.85 m 
1.31 m 
1.76 m 
1.47 m 
30  3.77 dd (5.3, 10.5)  3.80 dd (5.1, 10.5)  3.86 dd (5.4, 11.5)  2.91 m  2.30 m 
32  1.65 m 
1.09 m 
1.71 m 
1.13 m 
1.62 m 
1.09 m 
2.07 m 
1.04 m 
1.96 dd (10.0, 15.4) 
1.70 dd (2.0, 15.4) 
33  4.80 m  4.82 m  4.82 brt  2.10 m 
1.83 m 
4.26 dd (2.0, 10.0) 
36  2.18 dd (8.3, 19.3) 
2.06 dd (8.8, 19.3 ) 
2.21 dd (8.8, 19.3)  
2.03 m 
2.21 m 
2.05 m 
2.47 m 
1.98 dd (5.4, 18.3) 
2.12 d (8.1) 
2.12 d (8.1) 
37  1.66 s  1.67 s  1.67 s  1.54 s  1.63 s 
38  1.65 s  1.64 s  1.67 s  1.69 s  1.53 s 
39  0.99 s  1.09 s  1.19 s  0.98 s  1.52 s 
40  0.97 s  0.99 s  0.99 s  0.92 s  1.06 s 
OMe  3.42 s  3.39 s  3.42 s  3.39 s  3.40 s 
Ac    2.06 s       
OH-26  4.53 br         
OH-27        4.18 s   
OH-30        4.49 br   
OH-31  3.98 s  4.14 s  4.21 s     
OH-33  4.40 br  4.45 br  4.46 br    4.63 br 
 Mar. Drugs 2010, 8  
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The relative configurations of the stereogenic centers in 1 were determined on the basis of NOE 
relationships  (Figure  2)  and  J  values.  The  NOE  relationship  between  H-2  (H  3.47)  and  OMe 
suggested cis-conjunction of rings A and B. The exclusive -face of the methyl ester group as found in 
all known biscembranes led to  the biogenetical  assignment of  the  methyl  ester at  C-1 of  1  to  be  
-oriented. The obvious NOE correlation between H-22 (δH 4.78)/H-2 suggested the spatial vicinity of 
the two protons, thus  H-21 was  -oriented. The NOE  correlations between H-21 (δH 3.38)/H3-38  
(δH 1.65), H3-38/H-26 (δH 3.01), and H3-38/H-30 (δH 3.77) indicated -orientations of H-26 and H-30, 
as  well  as  22E  configuration.  The  -orientation  of  H3-39  (δH  0.99)  was  evident  from  the  NOE 
relationship between H-26 and H-28a (δH 2.25), which further correlated to H-30, while the assignment 
of  H-33  was  based  on  the  NOE  interactions  from  OH-33  (δH  4.40)  to  H-21,  H3-38,  and  H3-40 
(Figure 2).  In  addition,  the  NOE  relationship  between  H-30/H3-40  (δH  0.97)  suggested  H3-40  to  
be -oriented. 
Figure 2. Key NOE correlations of 1, 4–6 related to rings B–D. 
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Lobophytone  P  (2)  has  a  molecular  formula  of  C43H66O10  as  determined  by  HR-ESIMS  
(m/z 765.4570 [M + Na]
+), indicating 42 amu more than that of 1. Comparison of NMR data revealed 
that the structure of 2 was closely related to that of 1, except for the presence of an acetyl group as 
evident from the 
13C NMR signals at δC 171.3 (Cq) and 21.4 (CH3) and the corresponding 
1H NMR 
signal at δH 2.06 (3H, s). The HMBC correlation from H-26 (δH 4.56, d, J = 10.8 Hz) to the acetyl 
carbonyl carbon ascertained the location of the acetoxy group at C-26. The similar NOE and NMR Mar. Drugs 2010, 8  
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data of 2 and 1 indicated that 2 shared the same configurations of the stereogenic centers of 1. Thus, 
compound 2 was determined to be a C-26 acetylated analogue of 1. 
Lobophytone  Q  (3)  has  a  molecular  formula  of  C41H63O8Cl  as  determined  by  HR-ESIMS  
(m/z 741.4096 [M + Na]
+, calcd 741.4104), indicating 10 degrees of unsaturation and the presence of a 
chlorine atom. The 1D and 2D NMR spectroscopic analysis revealed that the structure of 3 was also 
closely related to that of 1. The presence of two D2O exchangeable protons at δH 4.18 (s) and 4.46 (br) 
was attributed to two hydroxy groups, which were deduced to be attached at C-31 and C-33, based on 
the HMBC interactions from OH-31 (δH 4.18, s) to C-30 (δC 90.1), C-31 (δC 73.2) and C-32 (δC 40.7), 
and the COSY correlation between OH-33 (δH 4.46, bs) and H-33 (δH 4.82). The chlorine atom of 3 
was assumed to be substituted at C-26 according to the upfield-shifted C-26 (δC 65.1), which showed 
around Δʴ 5 less than the same carbon of 1 linked by hydroxy group. The relative configurations of the 
chiral centers in 3 were in agreement with those of 1 based on the similar NMR and NOE data. 
The  molecular  formula  of  lobophytone  R  (4)  was  determined  as  C41H64O8  on  the  basis  of 
HR-ESIMS (m/z 685.4670 [M + H]
+), implying 10 degrees of unsaturation. Comparison of NMR data 
indicated that 4 is a biscembranoid possessing the same partial structure, with respect to rings A and B, 
of 1. However, the obvious downfield shifted C-26 (δC 77.8) and C-31 (δC 80.5), and the upfield 
shifted  C-27  (δC  74.7)  and  C-30  (δC  80.0),  in  comparison  with  the  corresponding  carbons  of  1, 
suggested that 4 contains an ether bridge at C-26/C-31 in ring C rather than C-27/C-30 ether bond of 1. 
The HMBC correlation from H-26 (δH 3.39) to C-31 confirmed this assignment. The COSY correlation 
between OH (δH 4.49, br)/H-30 (δH 2.91) and the HMBC relationships from OH (δH 4.18) to C-26 and 
C-27 disclosed two hydroxy groups at C-27 and C-30, respectively. The NOE relationships observed 
between H-2 (δH 3.49, m)/H-22 (δH 4.94, d,  J = 11.5 Hz), H-22/H-26, and H-26/H3-40 (δH 0.92) 
indicated H-26 and H3-40 to be -oriented, while the NOE correlations between OH-27 (δH 4.18)/H-26, 
H-30 (δH 2.91, m)/H-29a (δH 1.31, m), and H3-39 (δH 0.98)/H-29a assigned to H3-39 and H-30. 
Lobophytone  S  (5)  has  a  molecular  formula  of  C41H62O7,  as  determined  by  HR-ESIMS 
(m/z 689.4384 [M + Na]
+). The NMR spectroscopic data of 5 (Tables 1 and 2) indicated that it is a 
biscembrane,  structurally  related  to  ximaolide  A  [3],  a  biscembrane  isolated  from  soft  coral 
Sarcophyton tortuosum. Analysis of the NMR spectroscopic data revealed an additional vinyl group 
(δC 125.1, 132.8) in ring C of 5, in addition to the double bond located at C-22/C-23. This double bond 
was deduced to be located at C-26/C-27 based on the COSY and HMBC correlations. The carbon 
resonances of C-30 (δC 59.8, CH) and C-31 (δC 59.7, Cq) were attributed to epoxy carbons, while a 
hydroxy group linked to C-33 was confirmed by the HMBC correlations from H-33 (δH 4.26, dd,  
J = 2.0, 10.0 Hz) to C-21 and C-35 and the COSY relationship between OH (δH 4.63, br)/H-33. The 
NOE correlations between H3-39 (δH 1.52)/H2-25 (δH 2.00, 2.22) and H-22 (δH 4.70)/H2-24 (δH 1.92, 
2.07)  were  in  accordance  with  22E  and  26E  geometries  (Figure  2).  The  NOE  relationships  of  
H-33/H-30 (δH 2.30, m), H-33/H-22, and H-22/H-2 led to the assignment of β-faces of H-30 and H-33 
and the trans-configuration of the epoxide group. 
Lobophytone  T  (6)  has  a  molecular  formula  of  C22H34O5  as  determined  by  HR-ESIMS  
(m/z 401.2292 [M + Na]
+), implying six degrees of unsaturation. The 
1H MMR displayed five methyl 
singlets including two olefinic methyls at δH 1.65 (3H, s) and 1.80 (3H, s) and an acetyl methyl group 
at δH 1.87 (3H, s), in addition to four olefinic protons for an AB spin system at δH 6.02 (d, J = 11.3 Hz) 
and 6.03 (d, J = 11.3 Hz) and for the exo-methylene at δH 4.86 (brs) and 4.82 (brs). The COSY Mar. Drugs 2010, 8  
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correlations established the segments from C-2 to C-3, C-5 to C-7, C-9 to C-11, and C-13 to C-14, 
while 
13C  NMR  and  HMQC  data  indicated  the  methines  of  C-7  (δC  85.0),  C-11  (δC  70.5)  and  
C-14 (δC 69.7) bearing oxygen atom. The HMBC relationships connected each segment to form a 
backbone that featured a cembrane with 14-membered ring. An isopropene was deduced to position at 
C-1  based  on  the  HMBC  cross-peaks  from  H2-16  (δH  4.86,  4.82)  and  H3-17  (δH  1.80)  to  
C-1 (δC 143.5), while additional HMBC correlations indicated two vinyl groups to be conjugated at 
C-1/C-2 and C-3/C-4. The HMBC correlations from H3-19 (δH 1.01) to C-7, C-8 (δC 69.2, Cq), and 
C-9 (δC 32.2), and from H3-20 (δH 1.05) to C-11, C-12 (δC 73.7, Cq), and C-13 (δC 44.3), in addition to 
the HMBC relationship from H-7 (δH 3.26) to C-11 established an ether bridge which linked C-7 and 
C-11. The acetoxy group was deduced to position at C-14 on the basis of the HMBC correlations from 
H-14 (δH 6.01) to the acetyl carbonyl carbon and to C-1, C-2, and also C-15 (δC 144.2, Cq). Thus, C-8 
and C-12 were hydroxylated, and the gross structure of 6 was established as shown in Figure 1. The 
relative  configurations  of  the  chiral  centers  in  6  were  determined  through  J  values  and  NOESY 
analysis. The coupling constants of H-11 (H 3.71, dd, J = 2.7, 11.7 Hz) suggested its axial orientation 
in the chair-conformation of the perhydropyrano ring, while the NOE relationship between H-11/H-14 
indicated the same face (-orientation) of both protons. The NOE interactions of OH-12 (H 4.03, s) 
with  H-11  and  H-14  assigned  to  OH-12,  whereas  the  NOESY  cross-peaks  between  H-11/H-9a  
(H 1.50, m), H3-19/H-9a, and H-7/OH-8 (H 3.95, s) suggested -orientation for H-7 and OH-8. 
The “monomeric” cembrane lobophytone T (6) is likely a precursor (diene) to form the right part of 
biscembranes when it reacted with methyl tortuosoate [6]. Thus, it provided new evidence to support 
the  plausible  biogenetic  pathway  to  generate  biscembranes.  It  is  noted  that  all  of  the  isolated 
biscembranoids (1–5) maintained the same partial structure of ring A, which was considered to be 
derived from  methyl  tortuosoate as  a cembranoid-dienophile. The difference was  found in  ring C 
where epoxide rearrangement, oxidation, acetylation, and halogen substitution occurred. 
In  primary  bioassays,  compound  3  showed  significant  inhibition  against  lipopolysaccharide 
(LPS)-induced nitric oxide (NO) production in mouse peritoneal macrophages with IC50 = 2.8 µ M, 
whereas the other compounds showed weak activity (IC50 > 10 µM). In addition, all compounds were 
weakly cytotoxic toward the mouse peritoneal  macrophages (IC50 > 10 µM). The antibiotic assay 
indicated  that  compounds  3  and  6  exhibited  strong  inhibition  against  Staphylococcus aureus, 
S. pneumoniae, and Saccharomyces cerevisiae with the inhibitory rates around 90% at 20 µg/mL, but 
all  compounds  possessed  weakly  inhibitory  activity  against  Pseudomonas aerugonisa, 
Escherichia coli, Candida albicans, and Aspergillus fumigatus. 
3. Experimental Section 
3.1. General Procedures  
Optical rotations were measured on a Perkin-Elmer 243B polarimeter. IR spectra were determined 
on a Thermo Nicolet Nexus 470 FTIR spectrometer. 
1H and 
13C NMR and 2D NMR spectra were 
recorded on an Avance-500 FT 500 MHz NMR spectrometer using TMS as an internal standard. 
δ values are expressed in parts per million (ppm), and J values are reported in Hertz (Hz). HR-ESIMS 
data were obtained from Bruker APEX IV instrument. Low pressure column chromatography was Mar. Drugs 2010, 8  
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carried out with silica gel (160–200 and 200–300 mesh), and GF254 silica gel for TLC was provided by 
Qingdao Marine Chemistry Co. Ltd. HPLC chromatography was performed on an Alltech instrument 
(426-HPLC  pump,  Alltech  UV–vis-200  detector)  equipped  with  Kromasil  semipreparative  column 
(10 µm, ODS, 10 mm ×  250 mm) and YMC-Pack C8 (5 µm, 10 mm ×  250 mm) column. 
3.2. Animal Material  
Soft coral Lobophytum pauciflorum was collected from the inner coral reef at a depth of 10 m in 
Sanya Bay, Hainan Island of China, in 2008. Fresh samples were frozen immediately. The specimen 
was identified by Leen van Ofwegen (National Museum of National History Naturalis). The coral 
specimen (HSF-6) was deposited at State Key Laboratory of Natural and Biomimetic Drugs, Peking 
University, China. 
3.3. Extraction and Isolation  
The frozen soft coral L. pauciflorum (2.3 kg) was homogenized and then extracted with EtOH 
(twice, 5 L/each time). The concentrated extract was desalted by dissolving in MeOH to yield a MeOH 
soluble fraction which  was  concentrated to an  oily residue  (92.7  g). This  residue  was  partitioned 
between H2O and EtOAc, and then the water phase was extracted with n-BuOH. The EtOAc fraction 
(12.1 g) was subjected to silica gel (200–300 mesh) column chromatography, eluting with a gradient 
(petroleum ether–acetone, 20:1, 10:1, 3:1, 1:1) to obtain seven fractions (F1–F7).Fractions F1–F4 
mainly contained lipids and steroids, as detected by 
1H NMR, while F5 and F6 showed the 
1H NMR 
spectral features of terpenoids. Thus, F5 and F6 were combined (1.69 g) and subsequently subjected to 
Sephadex LH-20 column eluting with CH2Cl2-MeOH (1:2) to afford 6 portions (P1–P6). P2 (180 mg) 
showing  blue-green  spots  after  spraying  with  anisaldehyde  reagent  was  further  separated  on 
reversed-phase  semi-preparative  HPLC  with  CH3CN-H2O  (61%)  as  a  mobile  phase  to  obtain 
1 (12.5 mg). P3 (49.2 mg) was separated on ODS HPLC with MeOH–H2O (82%) as a mobile phase to 
afford 4 (7.6 mg), while 2 (8.1 mg) was obtained from P4 (40.5 mg) by the same separation process as 
that for P3. Followed by the same process as for P3 and P4, 5 (7.1 mg), 3 (17.7 mg), 3 (14.5 mg), and 
6 (5.4 mg) were separated and purified from P5 (112.7 mg) by reversed-phase semi-preparative HPLC 
(ODS) with CH3CN–H2O (87%) as a mobile phase. 
3.3.1. Lobophytone O (1) 
Amorphous powder; [ʱ]
25 
D + 140.4 (c 1.25, CHCl3); IR (KBr) νmax 3413, 2960, 2931, 1740, 1705, 
1459, 1436, 1386, 1370, 1206, 1086, 1049, 1026 cm
−1; 
1H and 
13C NMR data, see Tables 1 and 2; 
HR-ESIMS m/z 723.4428 [M + Na]
+ (calcd for C41H64NO9Na, 723.4442). 
3.3.2. Lobophytone P (2)  
Amorphous powder; [ʱ]
25 
D + 133.7 (c 0.33, CHCl3); IR (KBr) νmax 3467, 2959, 2928, 1741, 1708, 
1459, 1373, 1237, 1028 cm
−1; 
1H and 
13C NMR data, see Tables 1 and 2; HR-ESIMS m/z 765.4570  
[M + Na]
+ (calcd for C43H66O10Na, 765.4548). Mar. Drugs 2010, 8  
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3.3.3. Lobophytone Q (3)  
Amorphous powder; [ʱ]
25 
D + 121.2 (c 1.30, CHCl3); IR (KBr) νmax 3440, 2958, 2930, 1741, 1706, 
1459, 1374, 1206, 1027 cm
−1; 
1H and 
13C NMR data, see Tables 1 and 2; HR-ESIMS m/z 741.4096  
[M + Na]
+ (calcd for C41H63O8NaCl, 741.4104). 
3.3.4. Lobophytone R (4)  
Amorphous powder; [ʱ]
25 
D + 151.1 (c 0.51, CHCl3); IR (KBr) νmax 3423, 2958, 2928, 1709, 1460, 
1376, 1203, 1050 cm
−1; 
1H and 
13C NMR data, see Tables 1 and 2; HR-ESIMS m/z 685.4670 [M + H]
+ 
(calcd for C41H65O8, 685.4674). 
3.3.5. Lobophytone S (5)  
Amorphous powder; [ʱ]
25 
D + 101.1 (c 0.60, CHCl3); IR (KBr) νmax 3399, 2958, 2927, 1742, 1706, 
1459,  1435,  1387,  1204,  1074  cm
−1; 
1H  and 
13C  NMR  data,  see  Tables  1  and  2;  HR-ESIMS 
m/z 689.4384 [M + Na]
+ (calcd for C41H62O7Na, 689.4388). 
3.3.6. Lobophytone T (6)  
Colorless oil; [ʱ]
25 
D + 36.5 (c 0.27, CHCl3); IR (KBr) νmax 3423, 2969, 2935, 1734, 1453, 1375, 
1246, 1071, 1026 cm
−1; 
1H NMR  (ppm, DMSO-d6): 6.02 (1H, d, J = 11.3 Hz, H-2), 6.03 (1H, d,  
J = 11.3 Hz, H-3), 2.47 (1H, m, H-5a), 1.96 (1H, m, H-5b), 1.44 (1H, m, H-6a), 2.00 (1H, m, H-6b), 
3.26 (1H, brd, J = 8.1 Hz, H-7), 1.42 (1H, m, H-9a), 1.50 (1H, m, H-9b), 1.43 (1H, m, H-10a), 
1.77 (1H, m, H-10b), 3.71 (1H, dd, J = 2.7, 11.7 Hz, H-11), 1.85 (1H, m, H-13a), 1.97 (1H, m, H-13b), 
6.01 (1H, brd, J = 10.0 Hz, H-14), 4.82 (1H, br, H-16a), 4.86 (1H, br, H-16b), 1.80 (3H, s, H-17), 
1.65 (3H, s,  H-18), 1.01 (3H, s, H-19), 1.05  (3H, s,  H-20), 1.87 (3H,  s,  Ac); 
13C NMR    (ppm, 
DMSO-d6): 143.5 (Cq, C-1), 120.5 (CH, C-2), 119.6 (CH, C-3), 137.8 (Cq, C-4), 39.4 (CH2, C-5), 
21.6 (CH2, C-6), 85.0 (CH, C-7), 69.2 (Cq, C-8), 32.2 (CH2, C-9), 19.9 (CH2, C-10), 70.5 (CH, C-11), 
73.7 (Cq, C-12), 44.3 (CH2, C-13), 69.7 (CH, C-14), 144.2 (Cq, C-15), 114 (CH2, C-16), 23.0 (CH3, 
C-17),  18.1  (CH3,  C-18),  27.8  (CH3,  C-19),  25.0  (CH3,  C-20),  169.9  (Cq,  Ac),  21.5  (CH3,  Ac); 
HR-ESIMS m/z 401.2292 [M + Na]
+ (calcd for C22H34O5Na, 401.2298). 
3.4. Assay for Inhibition of Nitric Oxide (NO) Production  
Dexamethasone (DEX, positive control, 20 mM in DMSO) and each compound (20 mM in DMSO) 
were diluted to 1–20 µM range at r.t. before experiment. The final percentage of DMSO in the reaction 
mixture was less than 0.5% (v/v). LPS (1 µg/mL), 4% sodium thioglycolate, RPMI1640, FBS, PBS, 
MTT  and  Griess  reagents  were  purchased  from  Sigma  (St.  Louis,  MO,  U.S.).  Mouse  peritoneal 
macrophages (PEMФ) were obtained from C57BL6J male mice, and then plated onto 48 well plates 
and cultured for 2 hrs  in DMEM containing 5% FBS at  5% CO2 in  37 ° C. Mouse PEMФ were 
incubated with compounds for 1 h at 37 ° C before stimulation with 1 g/mL of lipopolysaccharide 
(LPS) for 24 h. Cells (5 ×  10
5 cells) were preincubated at 37 ° C for 24 h in serum-free medium and NO 
production  was  monitored  by  measuring  nitrite  levels  in  culture  media  using  Griess  reagent. Mar. Drugs 2010, 8  
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Absorbance was measured  at 548 nm in incubated media with Griess reagent  for 10 min. Viable 
adherent cells were stained with MTT (2 µg/mL) for 4 h. The medium was then removed and the 
produced formazan crystals were dissolved in DMSO (200 µL). Absorbance was measured at 540 nm. 
One-way analysis of variance was applied for all statistical analyses by independent experiments, 
and data were represented as means ±  standard error of the measurement. Individual values were 
compared by t-test and a P-value < 0.01 to evaluate the significant. 
3.5. Antimicrobial and Antifungal Assays  
Antimicrobial  and  antifungal  bioassays  were  conducted  in  triplicate  following  the  method  as 
recommended by the National Center for Clinical Laboratory Standards (NCCLS) [10]. The bacterial 
strains Staphylococcus aureus, S. pneumoniae, Escherichia coli, and Pseudomonas aeruginosa were 
grown on Mueller-Hinton agar. The yeasts, Candida albicans and Saccharomyces cerevisiae, were 
grown  on  Sabouraud  dextrose  agar,  and  the  fungus,  Aspergillus  fumigatus,  was  grown  on  potato 
dextrose agar. Targeted microbes (3–4 colonies) were prepared from broth culture (bacteria: 37 ° C for 
24 h; fungus: 28 ° C for 48 h), and the final spore suspensions of bacteria (in MHB medium), yeasts 
(in SDB  medium),  and  fungus  (in  PDB  medium)  were  10
6  and  10
5  cells/mL  and  10
4  mycelial 
fragments/mL, respectively. Testing compounds (10 mg/mL as stock solution in DMSO and serial 
dilutions)  were  transferred  to  a  96-well  clear  plate  in  triplicate,  and  the  suspension  of  the  test 
microorganisms were added to each well (200 µL) (antimicrobial peptide AMP, streptomycin, and 
fluconazole were used as positive controls). After incubation, the absorbance at 595 nm was measured 
with  a  microplate  reader  (TECAN),  and  the  inhibition  rate  was  calculated  and  plotted  versus 
test concentrations. 
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